Private company

Chiasma (United States)

Chiasma (United States) is an American pharmaceutical preparations company based in Waltham, founded in 2001.1

Last updated Oct 20, 2026.

Overview

2001Founded1
  • IndustryPharmaceutical Preparations1
  • HeadquartersWaltham1
  • Websitewww.chiasmapharma.com
  • Incorporated inDE3
  • Business address140 Kendrick Street, Building C East, Needham, Ma 024943
  • Filer categoryNon-accelerated filer, Smaller reporting company3

What it owns

What Chiasma (United States) reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.0M4 Dec 31, 2020$654.0K4 Dec 31, 2019+56.9%
Accumulated depreciation$492.0K4 Dec 31, 2020$320.0K4 Dec 31, 2019+53.8%
Property and equipment, net$534.0K4 Dec 31, 2020$334.0K4 Dec 31, 2019+59.9%
Operating-lease assets (leased space)$985.0K4 Dec 31, 2020$1.4M4 Dec 31, 2019−28.2%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$15.5M4 Dec 31, 2020$27.9M4 Dec 31, 2019−44.5%
Debt securities available for sale$151.4M4 Dec 31, 2020$89.5M4 Dec 31, 2019+69.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$11.0M4 Dec 31, 2020
Work in process$3.9M4 Dec 31, 2020
Finished goods$312.0K4 Dec 31, 2020

Leadership

Who has led Chiasma (United States), and when. Pick a name to see everywhere that person has worked.

Board members and other officers (22)

Former names

  • CHIASMA INCSep 21, 2005 to Jul 1, 20113

Timeline

  1. Jun 17, 2019New chief executive Raj Kannan becomes CEO5
  2. Oct 25, 2016New chief executive Mark J. Fitzpatrick becomes CEO7
  3. Feb 12, 2016New chief executive Mark Leuchtenberger becomes CEO6
  4. 2001Founded Founded1

Filings

1 filings to the SEC since October 2021: 1 large holders. The latest 1:

  1. Feb 15, 2022SC 13G/A EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

1 such filings since October 2021:

  1. Feb 15, 2022SC 13G/A

SEC filer profile

How Chiasma (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCHIASMA, INC2
  • CIK0001339469
  • Filer statusNon-accelerated filer<br>smaller reporting company2
  • Incorporated inDelaware2
  • Fiscal year endsDecember 312
  • Industry code (SIC)2834 Pharmaceutical Preparations2
  • Business address140 Kendrick Street, Building C East, Needham, MA 024942
  • Phone617-928-53002
  • Shares outstanding57,894,177 as of Apr 30, 202130
  • Public float$195.2M as of Jun 30, 20204
  • On EDGAR sinceSep 21, 20052
  • Filings370 in all: 4 (108), 8-K (68), SC 13G/A (30), 3 (27), 10-Q (18), SC 13G (18), 425 (14), 424B5 (8)2
    All 37 form types

    DEFA14A (8), CORRESP (7), 10-K (6), D (6), DEF 14A (6), S-8 (5), S-8 POS (5), D/A (4), EFFECT (4), REGDEX (4), 3/A (2), 4/A (2), DRSLTR (2), S-3 (2), UPLOAD (2), 15-12B (1), 25-NSE (1), 424B4 (1), 5 (1), 8-A12B (1), CERTNAS (1), DEFM14A (1), DRS (1), DRS/A (1), POS AM (1), S-1 (1), S-1/A (1), S-1MEF (1), S-3/A (1)

  • Latest filingsAnnual report (10-K) Mar 4, 2021
    Quarterly report (10-Q) May 5, 2021
    Proxy statement (DEF 14A) Apr 26, 2021
    Latest 8-K (8-K) Aug 5, 2021